In 1980, health care in the United States took no more of a bite out of the economy than it did in any other developed country. Then we instituted cost controls. By 2000, U.S. health care cost twice as much as everyone else’s. By 2020 or 2025, we may be back to...
One of the most common ideas in the whole healthcare financing discussion is a moral one. Why, people say, should my taxes and my healthcare premiums go to take care of the huge medical problems of people who don’t take care of themselves? As one commenter on...
[This article first appeared in H&HN (Hospitals and Health Networks) Daily, January 24, 2012] 2012 and 2013 present a unique and compelling opportunity for health care executives to produce significant change. If we hope to be, as Buckminster Fuller said,...
Ten existential questions will make the difference between stumbling into the future and thriving The questions have changed. The key strategy questions that the C-suite must be asking—and getting actionable answers to—are different now than they were in the past,...
[From Hospitals & Health Networks Daily, September 20, 2011] There is fire in the valley and smoke in the mountains. A plague is on the land and danger is afoot. That may be — maybe — the good news. Health care is more unstable than it has been at any time in...
Traditional drug and device research aims to show whether a drug or device has a some positive effect, and doesn’t kill or hurt any more people than not using it. Comparative effectiveness research (CER), in contrast, compares the drug or device with all...
